Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.72
-0.05 (-0.24%)
Nov 21, 2024, 1:07 PM EST - Market open
Dianthus Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$46.43
Upside
+124.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +93.05% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +150.97% | Nov 11, 2024 |
| Raymond James | Raymond James | Buy Maintains $51 → $56 | Buy | Maintains | $51 → $56 | +170.27% | Nov 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $48 | Buy | Initiates | $48 | +131.66% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +93.05% | Sep 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +93.05% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +73.75% | Aug 9, 2024 |
| Baird | Baird | Buy Initiates $58 | Buy | Initiates | $58 | +179.92% | Jul 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +93.05% | May 16, 2024 |
| Wedbush | Wedbush | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +83.40% | May 10, 2024 |
| Raymond James | Raymond James | Buy Maintains $34 → $51 | Buy | Maintains | $34 → $51 | +146.14% | Apr 18, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $22 → $39 | Strong Buy | Maintains | $22 → $39 | +88.22% | Mar 22, 2024 |
| Wedbush | Wedbush | Buy Maintains $24 → $33 | Buy | Maintains | $24 → $33 | +59.27% | Mar 22, 2024 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +112.36% | Feb 15, 2024 |
| Wedbush | Wedbush | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +15.83% | Jan 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.